Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

OrthoPediatrics Corp. operates as a medical device company. The Company designs, develops, and commercializes orthopedic implants and instruments to improve the lives of children with orthopedic conditions. OrthoPediatrics markets surgical systems for trauma and deformity, bone fractures, and reconstruction procedures. OrthoPediatrics serves orthopedic market globally.
Website: orthopediatrics.com



Growth: Good revenue growth rate 10.9%, there is slowdown compared to average historical growth rates 26.1%. The revenue growth dynamics is moderately stable

Profitability: LTM EBITDA margin is negative, -8.4%. On average the margin is improving steadily. Gross margin is high, +73.9%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 60% of quarters (showing a gain of +$0.22 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -22.6% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 9.1% higher than minimum and 65.8% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.2x by EV / Sales multiple , the company can be 10.0% undervalued

Key Financials (Download financials)

Ticker: KIDS
Share price, USD:  (0.0%)17.78
year average price 20.25  


year start price 25.06 2025-02-13

max close price 26.31 2025-04-02

min close price 16.30 2025-10-10

current price 17.78 2026-02-12
Common stocks: 23 171 662

Dividend Yield:  0.0%
EV / Sales: 2.0x
Margin (EBITDA LTM / Revenue): -8.4%
Fundamental value created in LTM:
Market Cap ($m): 412
Net Debt ($m): 42
EV (Enterprise Value): 454
Price to Book: 1.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-13zacks.com

OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?

2026-01-12globenewswire.com

OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance

2025-10-28seekingalpha.com

OrthoPediatrics Corp. (KIDS) Q3 2025 Earnings Call Transcript

2025-10-28zacks.com

OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates

2025-10-09seekingalpha.com

OrthoPediatrics Corp. (KIDS) Q3 2025 Sales Call Transcript

2025-09-05globenewswire.com

OrthoPediatrics Corp. Announces Distribution Agreement with MY01 Inc.

2025-08-05seekingalpha.com

OrthoPediatrics Corp. (KIDS) Q2 2025 Earnings Call Transcript

2025-08-05fool.com

OrthoPediatrics (KIDS) Q2 Revenue Up 16%

2025-08-05zacks.com

OrthoPediatrics (KIDS) Reports Q2 Earnings: What Key Metrics Have to Say

2025-08-05zacks.com

OrthoPediatrics (KIDS) Reports Q2 Loss, Misses Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-08-06 2024-11-07 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-10-29 13:03:56 2025-08-06 15:25:16 2025-03-05 14:15:40 2024-11-07 14:37:35 2024-08-06 14:39:36 2024-05-07 17:18:49 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10 2022-03-03 14:56:02 2021-03-11 15:50:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 61M 61M 205M 55M 53M 45M 149M 40M 40M 32M 122M 35M 98M 71M
costOfRevenue 16M 17M 56M 15M 17M 18M 37M 9M 10M 8M 32M 9M 25M 16M
grossProfit 45M 44M 149M 40M 36M 27M 111M 31M 30M 24M 91M 26M 73M 55M
grossProfitRatio 0.739 0.721 0.734 0.682 0.607 0.774 0.759 0.746 0.741
researchAndDevelopmentExpenses 2M 2M 11M 3M 3M 3M 11M 2M 3M 2M 8M 2M 6M 5M
generalAndAdministrativeExpenses 29M 30M 103M 26M 27M 25M 73M 19M 20M 18M 58M 15M 46M 38M
sellingAndMarketingExpenses 19M 19M 64M 17M 17M 14M 53M 14M 13M 12M 46M 12M 40M 32M
sellingGeneralAndAdministrativeExpenses 48M 50M 167M 43M 39M 34M 126M 32M 33M 30M 104M 27M 86M 70M
otherExpenses 0 3M 0 0 -120 000 24 000 985 000 787 000 289 000 331 000 4M 0 150 000 6M
operatingExpenses 50M 55M 178M 46M 42M 37M 138M 34M 36M 32M 116M 29M 91M 82M
costAndExpenses 66M 72M 234M 60M 58M 54M 175M 43M 45M 40M 148M 38M 116M 98M
interestIncome 0 0 0 0 0 0 198 000 21 000 294 000 0 0 0 0 0
interestExpense 2M 1M 3M 404 000 261 000 637 000 0 21 000 294 000 566 000 2M 708 000 2M 3M
depreciationAndAmortization 5M 5M 19M 5M 5M 5M 17M 4M 4M 3M 13M 22M 11M 8M
ebitda -5M -778 000 -10M -3M -1M -5M -8M 2M -1M -5M -9M 18M -7M -22M
ebitdaratio -0.078 -0.013 -0.063 -0.017 -0.105 0.038 -0.031 -0.171 0.526
operatingIncome -5M -11M -30M -6M -6M -10M -27M -5M -6M -9M -25M -3M -18M -27M
operatingIncomeRatio -0.079 -0.174 -0.102 -0.107 -0.218 -0.113 -0.141 -0.272 -0.096
totalOtherIncomeExpensesNet -7M 4M -12M -4M -381 000 -613 000 5M -198 000 3M 1M 22M 18M 636 000 -7M
incomeBeforeTax -12M -7M -42M -9M -6M -10M -21M -4M -3M -7M -4M 14M -17M -34M
incomeBeforeTaxRatio -0.194 -0.116 -0.167 -0.115 -0.231 -0.094 -0.083 -0.234 0.412
incomeTaxExpense -125 000 49 000 -4M -1M -18 000 -3M -338 000 849 000 -401 000 -574 000 -5M -4M -1M -723 000
netIncome -12M -7M -38M -8M -6M -8M -21M -5M -3M -7M 1M 19M -16M -33M
netIncomeRatio -0.192 -0.116 -0.145 -0.114 -0.175 -0.115 -0.073 -0.215 0.53
eps -0.5 -0.3 -1.64 -0.34 -0.26 -0.34 -0.92 -0.2 -0.13 -0.3 0.06 0.88 -0.84 -1.82
epsdiluted -0.5 -0.3 -0.34 -0.26 -0.34 -0.2 -0.13 -0.3 0.87
weightedAverageShsOut 23M 23M 23M 23M 23M 23M 23M 23M 23M 23M 21M 21M 19M 18M
weightedAverageShsOutDil 23M 23M 23M 23M 23M 23M 23M 23M 23M 23M 21M 21M 19M 18M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-08 2023-03-01 2022-03-03 2021-03-11
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -3M 198 000 -2M -2M -3M
ebit -30M -26M -22M -18M -30M
nonOperatingIncomeExcludingInterest 0 -985 000 -4M -150 000 4M
netIncomeFromContinuingOperations -38M -21M 1M -16M -33M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -38M -21M 1M -16M -33M
epsDiluted -1.64 -0.92 0.059 -0.84 -1.82

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-08-06 2024-11-07 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-10-29 13:03:56 2025-08-06 15:25:16 2025-03-05 14:15:40 2024-11-07 14:37:35 2024-08-06 14:39:36 2024-05-07 17:18:49 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10 2022-03-03 14:56:02 2021-03-11 15:50:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 17M 45M 44M 51M 31M 24M 31M 11M 10M 35M 9M 35M 9M 30M
shortTermInvestments 41M 26M 25M 25M 0 26M 49M 72M 83M 73M 109M 85M 46M 55M
cashAndShortTermInvestments 58M 70M 69M 76M 31M 50M 80M 82M 93M 108M 118M 120M 55M 85M
netReceivables 51M 54M 42M 43M 42M 36M 35M 38M 34M 27M 25M 26M 18M 18M
inventory 129M 125M 117M 121M 116M 113M 106M 101M 91M 85M 78M 74M 58M 53M
otherCurrentAssets 8M 8M 2M 8M 6M 5M 6M 4M 4M 4M 1M 4M 3M 3M
totalCurrentAssets 246M 258M 237M 248M 194M 204M 226M 226M 223M 225M 227M 225M 134M 158M
propertyPlantEquipmentNet 51M 53M 59M 55M 53M 49M 41M 40M 40M 37M 34M 36M 29M 27M
goodwill 104M 99M 94M 91M 91M 91M 84M 81M 83M 84M 87M 88M 72M 71M
intangibleAssets 79M 80M 81M 66M 87M 89M 85M 85M 88M 80M 80M 81M 70M 64M
goodwillAndIntangibleAssets 183M 179M 175M 157M 177M 181M 168M 165M 171M 164M 167M 169M 142M 135M
longTermInvestments 0 0 2M 0 14M -5M 2M -5M -6M 0 190M 0 0 0
taxAssets 0 0 0 4M 5M 5M 0 5M 6M 6M 6M 0 4M 4M
otherNonCurrentAssets 14M 14M 0 25M -12M 4M 1M 621 000 614 000 -6M -195M 0 0 0
totalNonCurrentAssets 248M 246M 236M 241M 237M 233M 212M 206M 212M 201M 201M 205M 175M 166M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 493M 504M 473M 489M 431M 437M 439M 432M 435M 426M 428M 430M 308M 325M
accountPayables 7M 13M 9M 12M 17M 20M 13M 23M 21M 17M 11M 11M 9M 10M
shortTermDebt 166 000 164 000 160 000 158 000 156 000 11M 152 000 150 000 148 000 146 000 144 000 143 000 13M 12M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 0 19M 18M 0 6M 0 0 0
otherCurrentLiabilities 26M 26M 9M 23M 22M 16M 7M 7M 5M 18M 7M 18M 2M 8M
totalCurrentLiabilities 33M 39M 34M 35M 40M 46M 42M 48M 44M 35M 31M 29M 30M 35M
longTermDebt 99M 97M 73M 24M 10M 14M 10M 650 000 688 000 725 000 763 000 799 000 15M 14M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 3M 3M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 4M 4M 0 0 5M 5M 5M 5M 6M 6M 6M 5M 9M 10M
otherNonCurrentLiabilities 8M 9M 6M 59M 5M 2M 5M 557 000 568 000 11M 11M 7M 29M 31M
totalNonCurrentLiabilities 111M 109M 85M 84M 20M 21M 20M 10M 10M 18M 18M 18M 53M 55M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 8M 0 0 2M 0 434 000 0 0 0 0 293 000 323 000
totalLiabilities 144M 148M 119M 118M 59M 67M 62M 58M 55M 53M 49M 47M 83M 90M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 6000 6000 6000 6000 6000 6000 6000 6000 6000 6000 6000 6000 5000 5000
retainedEarnings -265M -253M -236M -219M -212M -206M -198M -191M -186M -184M -177M -169M -178M -162M
accumulatedOtherComprehensiveIncomeLoss -4M -5M -11M -7M -10M -7M -6M -12M -8M -6M -5M -7M 8M 8M
othertotalStockholdersEquity 618M 614M 597M 593M 583M 578M 575M 563M 559M
totalStockholdersEquity 349M 356M 355M 371M 371M 371M 377M 374M 380M 373M 379M 383M 225M 235M
totalEquity 349M 356M 355M 371M 371M 371M 377M 374M 380M 373M 379M 383M 225M 235M
totalLiabilitiesAndStockholdersEquity 493M 504M 489M 431M 437M 432M 435M 426M 430M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 493M 504M 473M 489M 431M 437M 439M 432M 435M 426M 428M 430M 308M 325M
totalInvestments 41M 26M 27M 25M 14M 26M 51M 72M 83M 73M 299M 85M 46M 55M
totalDebt 99M 97M 81M 25M 14M 24M 10M 800 000 836 000 871 000 907 000 942 000 29M 27M
netDebt 83M 53M 37M -26M -17M 722 000 -21M -10M -9M -34M -8M -34M 20M -4M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-08 2023-03-01 2022-03-03 2021-03-11
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 42M 35M 25M 18M 18M
otherReceivables 0 0 0 0 0
prepaids 7M 0 4M 0 0
totalPayables 9M 23M 11M 9M 10M
otherPayables 0 10M 0 0 0
accruedExpenses 14M 11M 7M 5M 5M
capitalLeaseObligationsCurrent 2M 0 0 0 0
capitalLeaseObligationsNonCurrent 6M 0 0 293 000 323 000
treasuryStock 0 0 0 0 0
additionalPaidInCapital 601M 580M 561M 395M 389M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS KIDS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-10-29 2025-08-06 2024-11-07 2024-08-06 2024-05-07 2023-11-07 2023-08-01 2023-05-02 2022-11-01
acceptedDate 2025-10-29 13:03:56 2025-08-06 15:25:16 2025-03-05 14:15:40 2024-11-07 14:37:35 2024-08-06 14:39:36 2024-05-07 17:18:49 2024-03-08 17:23:05 2023-11-07 16:47:48 2023-08-01 16:16:40 2023-05-02 15:46:03 2023-03-01 16:00:30 2022-11-01 16:48:10 2022-03-03 14:56:02 2021-03-11 15:50:32
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -12M -7M -38M -8M -6M -8M -21M -5M -3M -7M 1M 19M -16M -33M
depreciationAndAmortization 5M 5M 19M 5M 5M 5M 17M 4M 4M 4M 13M 3M 11M 8M
deferredIncomeTax -125 000 49 000 -5M -952 000 -510 000 -2M -1M 76 000 -401 000 -574 000 -5M -4M -1M -723 000
stockBasedCompensation 4M 5M 14M 4M 3M 3M 11M 2M 3M 2M 7M 2M 6M 6M
changeInWorkingCapital -2M -14M -23M 12M -8M -5M -32M -12M -7M -5M -18M -6M -13M -5M
accountsReceivables 3M -10M -5M -595 000 -6M 1M -10M -4M -7M -2M -4M 1M -466 000 -451 000
inventory 1M -7M -13M -4M -4M -7M -26M -10M -6M -6M -17M -4M -5M -12M
accountsPayables -6M -1M -4M -6M -2M 7M 1M 2M 4M 6M -209 000 -6M -567 000 3M
otherWorkingCapital -851 000 5M -709 000 22M 4M -6M 2M 431 000 2M -2M 3M 2M -6M 4M
otherNonCashItems 4M -203 000 6M -22M 24M 12M -623 000 1M -2M -289 000 -20M -19M 354 000 6M
netCashProvidedByOperatingActivities -581 000 -10M -27M -10M -6M -7M -27M -9M -4M -6M -22M -6M -13M -19M
investmentsInPropertyPlantAndEquipment -3M -3M -14M -1M -7M -6M -17M -2M -6M -5M -10M -1M -16M -11M
acquisitionsNet -9M -100 000 -20M 468 000 0 -21M -4M -546 000 -3M 0 -40M -32M 0 -3M
purchasesOfInvestments -15M 0 -26M 25M -50M 0 -49M -4M -45M 0 -110M 0 0 -55M
salesMaturitiesOfInvestments 0 0 50M 0 26M 23M 113M 17M 35M 37M 47M 14M 9M 796 000
otherInvestingActivites -467 000 0 -51M 26M 23M 13M 0 0 -85M
netCashUsedForInvestingActivites -27M -4M -27M 20M -4M 10M -18M 32M -104M
debtRepayment -282 000 25M 0 -426 000 -573 000 -36 000 -35 000 -36 000 -31M
commonStockIssued 0 0 0 0 0 139M 0 0 108M
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 58M -4M -573 000 -139M -2M 0 31M
netCashUsedProvidedByFinancingActivities -282 000 25M 58M -4M -573 000 -15 000 -2M -36 000 108M
effectOfForexChangesOnCash -20 000 383 000 -175 000 684 000 -2M 1M 633 000 -61 000 -197 000 -138 000 619 000 26 000 -658 000 -404 000
netChangeInCash -28M 11M 13M 22M 7M -9M 23M 923 000 -25M 26M 1M -2M -21M -42M
cashAtEndOfPeriod 19M 47M 46M 53M 31M 24M 33M 12M 11M 36M 10M 37M 9M 30M
cashAtBeginningOfPeriod 47M 35M 33M 31M 24M 33M 10M 11M 36M 10M 9M 39M 30M 72M
operatingCashFlow -581 000 -10M -27M -10M -6M -7M -27M -9M -4M -6M -22M -6M -13M -19M
capitalExpenditure -3M -3M -14M -1M -7M -6M -19M -2M -6M -5M -10M -1M -16M -11M
freeCashFlow -3M -14M -41M -11M -13M -13M -46M -11M -10M -11M -32M -7M -29M -30M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-03-05 2024-03-08 2023-03-01 2022-03-03 2021-03-11
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -3M -2M 0 -650 000 -796 000
netCashProvidedByInvestingActivities -13M 42M -113M -7M -70M
netDebtIssuance 57M 9M -137 000 -131 000 -25M
longTermNetDebtIssuance 57M 9M -137 000 -131 000 -25M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 21 000 139M 137 000 70M
netCommonStockIssuance 0 21 000 139M 137 000 70M
commonStockIssuance 0 21 000 139M 137 000 70M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -3M -2M -3M 0 2M
netCashProvidedByFinancingActivities 53M 7M 136M 6000 47M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-10-28 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-05-11 ET (fiscal 2025 q1)
2024 q4
2025-03-04 ET (fiscal 2024 q4)
2024 q3
2024-11-08 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-03-07 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-01 ET (fiscal 2023 q2)
2023 q1
2023-05-02 ET (fiscal 2023 q1)
2022 q4
2023-03-01 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-10-28 20:32 ET
OrthoPediatrics published news for 2025 q3
SEC form 8
2025-10-28 20:32 ET
OrthoPediatrics published news for 2025 q3
SEC form 8
2025-10-28 20:06 ET
OrthoPediatrics published news for 2025 q3
SEC form 8
2025-10-28 20:06 ET
OrthoPediatrics reported for 2025 q3
SEC form 10
2025-08-06 19:25 ET
OrthoPediatrics reported for 2025 q2
SEC form 8
2025-08-05 20:33 ET
OrthoPediatrics published news for 2025 q2
SEC form 8
2025-08-05 20:33 ET
OrthoPediatrics published news for 2025 q2
SEC form 8
2025-08-05 20:07 ET
OrthoPediatrics published news for 2025 q2
SEC form 8
2025-08-05 20:07 ET
OrthoPediatrics reported for 2025 q2
SEC form 8
2025-08-05 20:03 ET
OrthoPediatrics published news for 2025 q2
SEC form 8
2025-08-05 20:03 ET
OrthoPediatrics published news for 2025 q2
SEC form 8
2025-05-14 13:06 ET
OrthoPediatrics published news for 2025 q1
SEC form 8
2025-05-14 13:06 ET
OrthoPediatrics published news for 2025 q1
SEC form 10
2025-05-08 19:37 ET
OrthoPediatrics published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
OrthoPediatrics published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
OrthoPediatrics published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
OrthoPediatrics published news for 2025 q1
SEC form 8
2025-05-07 20:07 ET
OrthoPediatrics published news for 2025 q1
SEC form 8
2025-05-07 20:07 ET
OrthoPediatrics reported for 2025 q1
SEC form 8
2025-03-06 15:45 ET
OrthoPediatrics published news for 2024 q4
SEC form 8
2025-03-06 15:45 ET
OrthoPediatrics published news for 2024 q4
SEC form 10
2025-03-05 19:15 ET
OrthoPediatrics published news for 2024 q4
SEC form 10
2025-03-05 00:00 ET
OrthoPediatrics published news for 2024 q4
SEC form 8
2025-03-04 16:14 ET
OrthoPediatrics published news for 2024 q4
SEC form 8
2025-03-04 16:14 ET
OrthoPediatrics reported for 2024 q4
SEC form 8
2025-01-13 00:00 ET
OrthoPediatrics published news for 2024 q4
SEC form 8
2025-01-13 00:00 ET
OrthoPediatrics published news for 2024 q4
SEC form 10
2024-11-07 14:37 ET
OrthoPediatrics published news for 2024 q3
SEC form 8
2024-11-06 16:11 ET
OrthoPediatrics published news for 2024 q3
SEC form 8
2024-11-06 16:11 ET
OrthoPediatrics published news for 2024 q3
SEC form 10
2024-08-06 14:39 ET
OrthoPediatrics published news for 2024 q2
SEC form 10
2024-08-06 00:00 ET
OrthoPediatrics published news for 2024 q2
SEC form 8
2024-08-05 17:09 ET
OrthoPediatrics published news for 2024 q2
SEC form 8
2024-08-05 17:09 ET
OrthoPediatrics reported for 2024 q2
SEC form 10
2024-05-07 17:18 ET
OrthoPediatrics published news for 2024 q1
SEC form 10
2024-05-07 00:00 ET
OrthoPediatrics published news for 2024 q1
SEC form 8
2024-05-06 16:16 ET
OrthoPediatrics published news for 2024 q1
SEC form 8
2024-05-06 16:16 ET
OrthoPediatrics reported for 2024 q1
SEC form 10
2024-03-08 17:23 ET
OrthoPediatrics published news for 2023 q4
SEC form 10
2024-03-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-03-06 16:34 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-03-06 16:34 ET
OrthoPediatrics reported for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
OrthoPediatrics published news for 2023 q4
SEC form 10
2023-11-07 16:47 ET
OrthoPediatrics published news for 2023 q3
SEC form 10
2023-11-07 00:00 ET
OrthoPediatrics published news for 2023 q3
SEC form 8
2023-11-06 16:11 ET
OrthoPediatrics reported for 2023 q3
SEC form 10
2023-08-01 16:16 ET
OrthoPediatrics published news for 2023 q2
SEC form 10
2023-08-01 00:00 ET
OrthoPediatrics published news for 2023 q2
SEC form 6
2023-07-31 16:13 ET
OrthoPediatrics reported for 2023 q2
SEC form 8
2023-07-31 00:00 ET
OrthoPediatrics published news for 2023 q2
SEC form 6
2023-06-16 13:57 ET
OrthoPediatrics published news for 2023 q1
SEC form 10
2023-05-02 00:00 ET
OrthoPediatrics published news for 2023 q1
SEC form 8
2023-05-01 00:00 ET
OrthoPediatrics published news for 2023 q1
SEC form 6
2023-03-08 07:27 ET
OrthoPediatrics published news for 2022 q4
SEC form 10
2023-03-01 16:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 10
2023-03-01 00:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 6
2023-02-28 16:18 ET
OrthoPediatrics published news for 2022 q4
SEC form 8
2023-02-28 00:00 ET
OrthoPediatrics reported for 2022 q4
SEC form 6
2023-01-09 17:29 ET
OrthoPediatrics published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
OrthoPediatrics published news for 2022 q4
SEC form 10
2022-11-01 16:48 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-11-01 11:47 ET
OrthoPediatrics published news for 2022 q3
SEC form 10
2022-11-01 00:00 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-10-31 16:15 ET
OrthoPediatrics published news for 2022 q3
SEC form 8
2022-10-31 00:00 ET
OrthoPediatrics reported for 2022 q3
SEC form 6
2022-10-20 09:15 ET
OrthoPediatrics published news for 2022 q3
SEC form 6
2022-08-11 19:50 ET
OrthoPediatrics published news for 2022 q2
SEC form 10
2022-08-04 13:08 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-08-04 09:54 ET
OrthoPediatrics published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-08-03 16:14 ET
OrthoPediatrics published news for 2022 q2
SEC form 8
2022-08-03 00:00 ET
OrthoPediatrics reported for 2022 q2
SEC form 6
2022-06-15 11:54 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-06-14 08:07 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-06-01 12:26 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-05-10 10:34 ET
OrthoPediatrics published news for 2022 q1
SEC form 10
2022-05-05 16:25 ET
OrthoPediatrics reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
OrthoPediatrics reported for 2022 q1
SEC form 6
2022-05-04 16:13 ET
OrthoPediatrics published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
OrthoPediatrics reported for 2022 q1
SEC form 6
2022-04-15 11:16 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-04-04 08:00 ET
OrthoPediatrics published news for 2022 q1
SEC form 6
2022-03-04 11:51 ET
OrthoPediatrics published news for 2021 q4
SEC form 10
2022-03-03 14:56 ET
OrthoPediatrics published news for 2021 q4
SEC form 10
2022-03-03 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-03-02 16:14 ET
OrthoPediatrics published news for 2021 q4
SEC form 8
2022-03-02 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-01-10 10:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2022-01-06 15:33 ET
OrthoPediatrics published news for 2021 q4
SEC form 6
2021-11-08 11:29 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-11-04 16:23 ET
OrthoPediatrics published news for 2021 q3
SEC form 10
2021-11-04 15:36 ET
OrthoPediatrics published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-11-03 16:12 ET
OrthoPediatrics published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-10-13 16:10 ET
OrthoPediatrics published news for 2021 q3
SEC form 8
2021-10-13 00:00 ET
OrthoPediatrics published news for 2021 q3
SEC form 6
2021-08-12 13:04 ET
OrthoPediatrics published news for 2021 q2
SEC form 10
2021-08-05 15:40 ET
OrthoPediatrics published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
OrthoPediatrics published news for 2021 q2
SEC form 6
2021-08-04 16:41 ET
OrthoPediatrics published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
OrthoPediatrics published news for 2021 q2
SEC form 6
2021-06-03 08:23 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-28 08:46 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-10 07:30 ET
OrthoPediatrics published news for 2021 q1
SEC form 10
2021-05-06 11:30 ET
OrthoPediatrics published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-05-05 16:32 ET
OrthoPediatrics published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-04-16 08:36 ET
OrthoPediatrics published news for 2021 q1
SEC form 6
2021-03-30 13:38 ET
OrthoPediatrics published news for 2020 q4
SEC form 10
2021-03-11 15:50 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-03-10 16:38 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-15 09:20 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-12 09:01 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-11 16:39 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2021-01-05 08:49 ET
OrthoPediatrics published news for 2020 q4
SEC form 6
2020-12-30 20:00 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-12-14 16:10 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-11-10 16:43 ET
OrthoPediatrics published news for 2020 q3
SEC form 10
2020-11-05 16:47 ET
OrthoPediatrics published news for 2020 q3
SEC form 6
2020-11-04 17:12 ET
OrthoPediatrics published news for 2020 q3